tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rapport Therapeutics 9.62M share Secondary priced at $26.00

The deal priced below last closing price of $28.03. Goldman Sachs, Jefferies, TD Cowen and Stifel are acting as joint book running managers for the offering.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1